WinstonWınston
Back
M1 Kliniken AG logo

M1 Kliniken AG

M12.DE
63
Medical - Care Facilities · Healthcare
Price
€18.20
+0.00 (+0.00%)
Market Cap
€341.8M
Exchange
Frankfurt Stock Exchange
Winston Score
63
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Good
Growth
Good
Cash Flow
Strong
Stability
Exceptional
Valuation
Mixed
Dividends
Good

Winston Score History

The full picture

M1 Kliniken AG is a German healthcare company that runs a chain of clinics focused on aesthetic medicine and beauty treatments. Its core services include cosmetic procedures like Botox injections, laser treatments, and other non-surgical beauty services, sold directly to everyday consumers who want to improve their appearance. The company also operates a wholesale distribution business supplying medical and aesthetic products to other healthcare providers across Europe.

The company earns money through two main streams: fees paid by patients at its clinics and product sales through its distribution arm. M1 Kliniken operates primarily in Germany and other European markets, with a growing network of clinic locations that gives it some scale advantages over smaller independent providers. With a gross margin of only around 13%, the business runs on thin margins, and its main growth driver is expanding its clinic network — though rising competition in the fast-growing aesthetics market and cost pressures from labor and supplies remain key risks to watch.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+72.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

69.1%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€42M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

M1 Kliniken AG is growing revenue at 5% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.1% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 18.6M (2021) → 18.6M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.3%
Thin — 13.3% gross margin
Profit after running costs
Operating Margin
9.2%
Modest — 9.2% operating margin
Return on the money invested
ROCE
27.6%
Exceptional — 27.6% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+7.4%
Steady sales growth (+7.4% YoY)
Profit growth
EPS YoY
+39.5%
Earnings growing fast (+39.5% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
153%
Turns 153% of profit into real cash
Spare cash per sale
FCF Margin
9.2%
Modest free cash flow (9.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.04
Conservative — low debt load (0.04)
Covers its interest
Interest Cover
22.45x
Comfortably covers interest (22.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
15.2x
Fair value — P/E 15.2

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
-1.4
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
6.59%
Healthy income — 6.59% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial